5/11/23: Management of Pediatric Inflammatory Bowel Disease

Mentor:

Caroline Sierra, PharmD, BCPPS 

Associate Professor

Loma Linda University School of Pharmacy 

Description:

Review the management of pediatric inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), with a focus on the ECCO & ESPGHAN 2020 guideline updates on CD. This course will also highlight new data published on biologic therapy in the pediatric population since the 2020 guideline update.

Learning Objectives:

Upon successful completion of this knowledge-based course pharmacists should be able to:

1. Explain the complications of growth and development that can occur in patients with pediatric-onset inflammatory bowel disease (IBD).
2. Describe the current standard of care for inpatient pediatric IBD management.
3. Describe the role of Pediatric Ulcerative Colitis Activity Index (PUCAI) and Pediatric Crohn’s Disease Activity Index (PCDAI) scores in the assessment of pediatric patients with IBD.
4. Recognize the role of nutrition in disease progression and IBD management in pediatric patients.
5. Describe current and future research directions of pediatric IBD treatment, including new data on biologics.

Claim your CPE Credit

To obtain 1.0 contact hour of continuing pharmacy education credit (0.1 CEU), participants must participate in the live activities, and log on to the CEimpact website to complete the exam and evaluation.

1. Click on https://learn.ceimpact.com and login to CEImpact.
2. If you are new to the site, click on Create an account before logging in.
3. Enter the course code (provided at the end of the lecture) in the text box on the left of the screen and click Submit.
4. Click on My Courses (on the left of the screen) to locate the course.
5. Click on the course title to access the course.
6. Complete the exam (2 opportunities provided) and evaluation as prompted and click Submit.
7. The course will move to the Completed tab under My Courses.
8. The CPE Statement of Credit will be available on CPE Monitor, www.MyCPEMonitor.net.

CEimpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

0107-9999-23-194-L01-P |  0.1 CEUs/1.0 Hrs.

Faculty Disclosure:  Marissa Boujikian has no relevant financial relationships with ineligible companies to disclose. Off-label use of medications will be discussed during this presentation.

Course Format:  Live Webinar

Target Audience:  Pharmacists

Financial Support:  None

Course Fee:  There is no cost for this course; includes course, course materials, and CPE credit submission to CPE Monitor.